Physicians should consider an ‘opt-out’ approach to syphilis screening In 2024, the U.S. Centre for Disease Control estimated that syphilis cases had risen by 79% between 2018 to 2022, physicians should be screening all sexually active persons with new or multiple partners to help curb this. What do we know about mpox vaccine effectiveness?Dr. Isaac Bogoch has treated several patients with mpox, and notes the dramatic difference between cases who’ve been vaccinated and those who haven’t. Check out FIP’s video series on global pharmacy-based vaccination practices The four part video series explores policy evolution, prescribing authority and funding models for pharmacy-based vaccinations across seven countries. Updated Canadian recommendations on the use of pneumococcal vaccines in adults NACI issues new guidance on use of pneumococcal vaccines, incorporating the new 21-valent pneumococcal conjugate vaccine (Capvaxive). What’s new in vaccines? Given this rapid pace of growth, it can be challenging to keep current. This article offers an overview of vaccines recently approved and/or marketed in Canada to help make sense of all these recent changes. Strategies to deal with avian flu: Will Canada start vaccinating poultry? Experts at the Canadian Immunization Conference discussed Canada’s plans to prevent a pandemic. RSV immunization program roll-out in Ontario: The story so far Delivery of RSV immunization by family doctors better than expected. What’s the number needed to vaccinate to keep older adults out of long-term care? Data provides new way to frame discussions about influenza vaccines with older adults. POP QUIZ: Chikungunya vaccine Ixchiq, the first chikungunya vaccine, is now available in Canada. Which statement about Ixchiq is FALSE? New product: Nuvaxovid Get the info you need on this new product, part of our drug news roundup for December. First Previous 14 15 16 17 18 Next Last
